{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 401948686
| IUPAC_name = (7''S'')-7-{[4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene)<br />1,3-dithietane-2-carbonyl]amino}-7-methoxy-<br />3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-<br />5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefotetan.svg
| width = 250
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CDI|cefotetan}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = B 
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = Rx-only 
| legal_status =  
| routes_of_administration = Injection
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 69712-56-7
| ATC_prefix = J01
| ATC_suffix = DC05
| PubChem = 53025
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01330
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 47904
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 48SPP0PA9Q
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D00260
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 3499
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 474579
<!--Chemical data-->
| C=17 | H=17 | N=7 | O=8 | S=4
| molecular_weight = 575.623 g/mol
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@]2(OC)NC(=O)C3S/C(S3)=C(/C(=O)N)C(=O)O)CSc4nnnn4C)C(=O)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30)/b12-6-/t13?,15-,17+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SRZNHPXWXCNNDU-IXOPCIAXSA-N
}}
'''Cefotetan''' is an injectable [[antibiotic]] of the [[cephamycin]] type for prophylaxis and treatment of [[bacterial infection]]s. It is often grouped together with second-generation [[cephalosporin]]s and has a similar antibacterial spectrum, but with additional anti-anaerobe coverage.

Cefotetan was developed by [[Astellas Pharma|Yamanouchi]]. It is marketed outside Japan by [[AstraZeneca]] with the brand names '''Apatef''' and '''Cefotan'''.

== Adverse effects ==
The chemical structure of cefotetan, like that of several other cephalosporins, contains an ''N''-methylthiotetrazole (NMTT or 1-MTT) [[side chain]]. As the antibiotic is broken down in the body, it releases free NMTT, which can cause [[hypoprothrombinemia]] (likely due to [[enzyme inhibitor|inhibition]] of the [[enzyme]] [[vitamin K epoxide reductase]]) and a reaction with ethanol similar to that produced by [[disulfiram]] (Antabuse), due to inhibition of [[aldehyde dehydrogenase]].<ref name=Goldfrank>{{cite book |author=Stork CM |veditors=Nelson LH, Flomenbaum N, Goldfrank LR, Hoffman RL, Howland MD, Lewin NA |title=Goldfrank's toxicologic emergencies |chapter=Antibiotics, antifungals, and antivirals |chapterurl=https://books.google.com/books?id=cvJuLqBxGUcC&pg=PA847 |publisher=McGraw-Hill |location=New York |year=2006 |pages=847 |isbn=0-07-143763-0 |accessdate=2009-07-03}}</ref>

==Spectrum of bacterial susceptibility==
Cefotetan has a broad spectrum of activity and has been used to treat bacterial infections of the bone, skin, urinary tract, and lower respiratory tract. Notable species include ''Bacteroides, Streptococcus'', and ''Escherichia''. The following represents MIC susceptibility data for a few medically significant bacteria.<ref>{{cite web|title=Cefotetan Susceptibility and Minimum Inhibitory Concentration (MIC) Data|url=http://www.toku-e.com/Assets/MIC/Cefotetan.pdf|publisher=Toku-e}}</ref>

* ''Escherichia coli'': 0.06&nbsp;µg/mL
* ''Bacteroides fragilis'': ≤0.06&nbsp;µg/mL - 512&nbsp;µg/mL
* ''Clostridium perfringens'': 1&nbsp;µg/mL - 4&nbsp;µg/mL

== References ==
{{Reflist}}

== External links ==
* [http://www.cefotan.com/content/products/productDisplay.asp?id=32 Cefotan official web site] run by [[AstraZeneca]] US
* [http://www.rxlist.com/cgi/generic2/cefotet.htm Cefotetan] entry in RxList

{{CephalosporinAntiBiotics}}

[[Category:Acetaldehyde dehydrogenase inhibitors]]
[[Category:Cephalosporin antibiotics]]
[[Category:Tetrazoles]]
[[Category:Dithietanes]]